Justin A. Renz

Chief Financial Officer, EPIRUS Biopharmaceuticals, Inc.

Companies

ZEVRA THERAPEUTICS, INC.Chief financial officer Mar 19, 2026 to now¹
Ardelyx (United States)Chief financial officer Jun 8, 2020 to Nov 7, 2025²
Karyopharm Therapeutics Inc.Chief financial officer Aug 27, 2014 to Jan 24, 2017³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARZEVRA THERAPEUTICS, INC., Chief financial officer
2
SEC EDGARArdelyx (United States), Chief financial officer
3
SEC EDGARKaryopharm Therapeutics Inc., Chief financial officer